Shoulder hand syndrome after stroke
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Agreed to participate in this clinical trial and signed informed consent; 2. Aged 40-75 one full year of life; 3. In line with the diagnostic criteria of cerebral infarction patients; 4. In accordance with the traditional Chinese medicine after a stroke shoulder hand syndrome diagnostic criteria, phlegm and blood stasis resistance collaterals syndrome differentiation standards; 5. In line with the shoulder hand syndrome stage stage I of the standard, the onset of 2 week course of 3 months or less or less; 6. Imaging (CT or MRI) confirmed clinical classification for TACI or PACI OCSP; 7. VAS three points or more.
Exclusion criteria
Exclusion criteria: 1. (POCI), posterior circulation infarction patients with lacunar infarction (LACI). 2. Progress sex stroke, transient ischemic attack, cerebral hemorrhage and cerebral arteritis patients after cerebral infarction. 3. by a brain tumor, brain trauma, brain parasitic disease, rheumatic heart disease, coronary heart disease and other heart disease caused by atrial fibrillation cerebral embolism. 4. Acute vascular opening (such as thrombolysis, arteries, super early thrombus suction and stent angioplasty, etc.), such as treatment of the patients. 5. With bleeding tendency; Three months had severe bleeding. 6. With severe liver and kidney disease, hematopoietic system and metabolic diseases. 7. Severe and uncontrolled hypertension. 8. The law of patients with disability (blind, deaf, dumb, mental retardation, mental disorder and other reasons caused by physical disabilities affect the nerve function defect evaluators). 9. History of doubt or do have alcohol and drug abuse, or researchers think not suitable for the clinical subjects. 10. This test known or suspected drug allergies or allergic constitution. 11. Is in other clinical trials or any other drug clinical trials end does not exceed 3 months. 12. After a stroke shoulder pain patient has a periarthritis of shoulder and upper extremity fracture, peripheral nerve injury of upper limb function activity or cause pain diseases; 13. Except for acupuncture and moxibustion in the intervention and the Tong therapy also USES other therapies and the control group did not use this method.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| VAS;VAS;GEPI; | — |
Secondary
| Measure | Time frame |
|---|---|
| Fugl - Meyer upper limb movement function score;ADL;NIHSS;TCM symptom score;TCM symptom score; | — |
Countries
China